Clinical Trial Site

Rapid City, South Dakota 57701

0 studies enrolling now · 4 studies all time

What they study most

High Cardiovascular Risk, Hypertension, Iron Deficiency Anemia

Studies at this site

• Zilebesiran as Add-on Therapy in Patients With High Cardiovascular Risk and Hypertension Not Adequately Controlled by Standard of Care Antihypertensive Medications (KARDIA-3) — Completed
• A Phase III Safety Study of Ferumoxytol Compared to Ferric Carboxymaltose for the Treatment of Iron Deficiency Anemia (IDA) — Completed
• A Trial Comparing Ferumoxytol With Placebo for the Treatment of Iron Deficiency Anemia — Completed
• A Trial of Ferumoxytol for the Episodic Treatment of Iron Deficiency Anemia — Completed